Trials / Unknown
UnknownNCT01745081
Comparison of 20% Mannitol and 3% Hypertonic Saline for Cerebral Relaxation During Elective Supratentorial Craniotomies
Comparison of the Efficacy Between 20% Mannitol and 3% Hypertonic Saline, Given as a Bolus at the Beginning of Elective Supratentorial Craniotomy for Tumor Resection, in Favoring Cerebral Relaxation Evaluated by a Sub-dural Intracranial Pressure Measurement.
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Université de Sherbrooke · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Mannitol 20% has long been used to treat elevated intracranial hypertension in trauma and intensive care settings. More recent data indicate that hypertonic saline may be as effective or more effective than mannitol for this purpose, with possible fewer side effects. This study compares both agents in favoring cerebral relaxation during elective supratentorial procedures for tumor resection. Study hypothesis: 3% hypertonic saline will provide better cerebral relaxation with fewer side effects than 20% mannitol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 20% mannitol bolus administration | |
| DRUG | Hypertonic saline 3% bolus administration |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2012-12-07
- Last updated
- 2012-12-07
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01745081. Inclusion in this directory is not an endorsement.